These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 30380064)
1. Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life. Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman S; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM Inflamm Bowel Dis; 2019 May; 25(6):e62-e63. PubMed ID: 30380064 [No Abstract] [Full Text] [Related]
2. The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life. Dai C; Jiang M; Huang YH Inflamm Bowel Dis; 2019 May; 25(6):e61. PubMed ID: 30380063 [No Abstract] [Full Text] [Related]
3. Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life. Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman S; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM Inflamm Bowel Dis; 2019 Feb; 25(3):592-600. PubMed ID: 30215805 [TBL] [Abstract][Full Text] [Related]
4. Visceral adiposity predicts post-operative Crohn's disease recurrence. Holt DQ; Moore GT; Strauss BJ; Hamilton AL; De Cruz P; Kamm MA Aliment Pharmacol Ther; 2017 May; 45(9):1255-1264. PubMed ID: 28244124 [TBL] [Abstract][Full Text] [Related]
5. Letter: reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn's disease-Authors' reply. Feathers A; Swaminath A; Ananthakrishnan AN; Falzon L; Li Ferry S Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1121. PubMed ID: 29105134 [No Abstract] [Full Text] [Related]
6. Profile of Consecutive Fecal Calprotectin Levels in the Perioperative Period and Its Predictive Capacity for Early Endoscopic Recurrence in Crohn's Disease. Liu R; Guo Z; Cao L; Wang Z; Gong J; Li Y; Zhu W Dis Colon Rectum; 2019 Mar; 62(3):318-326. PubMed ID: 30451756 [TBL] [Abstract][Full Text] [Related]
7. The Use of Fecal Calprotectin and Intestinal Ultrasound in the Evaluation and Management of Stricturing Crohn's Disease in Pregnancy. Prentice R; Wright EK; Flanagan E; Ross AL; Bell SJ Inflamm Bowel Dis; 2022 Jan; 28(1):e13-e16. PubMed ID: 34751772 [No Abstract] [Full Text] [Related]
8. Association between disease duration and usefulness of fecal calprotectin measurement in patients with Crohn's disease. Eder P; Stawczyk-Eder K; Łykowska-Szuber L; Krela-Kaźmierczak I; Klimczak K; Szymczak A; Szachta P; Linke K Pol Arch Med Wewn; 2014; 124(1-2):51-7. PubMed ID: 24424551 [TBL] [Abstract][Full Text] [Related]
9. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Sipponen T; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M Inflamm Bowel Dis; 2008 Jan; 14(1):40-6. PubMed ID: 18022866 [TBL] [Abstract][Full Text] [Related]
10. Serum calprotectin as a biomarker for Crohn's disease. Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E; J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231 [TBL] [Abstract][Full Text] [Related]
11. Fecal calprotectin in Crohn's disease: new family ties. Tamboli CP; Richard F; Colombel JF Gastroenterology; 2003 Jun; 124(7):1972-4. PubMed ID: 12806631 [No Abstract] [Full Text] [Related]
13. Level of Fecal Calprotectin and the Severity of Small Bowel Crohn's Disease. Dai C; Sun MJ; Jiang M Clin Gastroenterol Hepatol; 2017 Feb; 15(2):320-321. PubMed ID: 27670382 [No Abstract] [Full Text] [Related]
14. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study. Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809 [TBL] [Abstract][Full Text] [Related]
15. Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin. Vázquez Morón JM; Pallarés Manrique H; Machancoses FH; Ramos Lora M; Ruiz Frutos C Rev Esp Enferm Dig; 2017 Feb; 109(2):130-136. PubMed ID: 28071062 [TBL] [Abstract][Full Text] [Related]
16. Is fecal calprotectin useful for monitoring endoscopic disease activity in patients with postoperative Crohn's disease? Yamamoto T; Kotze PG J Crohns Colitis; 2013 Dec; 7(12):e712. PubMed ID: 23999186 [No Abstract] [Full Text] [Related]
17. Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines. Bourgonje AR; von Martels JZH; de Vos P; Faber KN; Dijkstra G PLoS One; 2018; 13(2):e0193202. PubMed ID: 29466406 [TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease. Egea Valenzuela J; Pereñíguez López A; Pérez Fernández V; Alberca de Las Parras F; Carballo Álvarez F Rev Esp Enferm Dig; 2016 Jul; 108(7):394-400. PubMed ID: 27312194 [TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy. Lasson A; Strid H; Ohman L; Isaksson S; Olsson M; Rydström B; Ung KA; Stotzer PO J Crohns Colitis; 2014 Aug; 8(8):789-95. PubMed ID: 24418661 [TBL] [Abstract][Full Text] [Related]
20. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease. Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]